MedTrace Logo

Analysis of the Enteric Nervous System Using Colonic Biopsies

NCT01353183 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2013-09-19

No results posted yet for this study

Summary

The aim of this project is to develop an original biomarker for Parkinson's disease (PD) and other parkinsonian syndromes (multiple system atrophy and progressive supranuclear palsy) based upon the detection of pathological alpha-synuclein species in routine colonoscopic biopsies.

Conditions

Interventions

PROCEDURE

colonoscopy or rectosigmoidoscopy

Usual procedure

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • DERKINDEREN Pascal, Professor · Nantes University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01353183 on ClinicalTrials.gov